EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Alzamend Neuro, Inc. (ALZN) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
$-2.70M |
|
-- |
|
-- |
|
$2.70M |
|
$-2.70M |
|
$-0.00M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.70M |
|
$-2.67M |
|
2.11M |
|
2.11M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$5.93M |
|
$0.40M |
|
$0.40M |
|
$6.33M |
|
$0.98M |
|
-- |
|
-- |
|
$0.98M |
|
$5.34M |
|
$5.34M |
|
$5.34M |
|
3.14M |
|
| Cash Flow Statement Financials | |
$-2.36M |
|
-- |
|
$4.04M |
|
$3.95M |
|
$5.62M |
|
$1.67M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-2.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.58% |
|
-50.58% |
|
-42.72% |
|
-50.58% |
|
$1.70 |
|
$-1.12 |
|
$-1.12 |
|